Natus Medical Incorporated (NTUS) Stock
NTUS is no longer traded. Natus Medical Incorporated was taken private by ArchiMed on July 21, 2022.
Each NTUS share was exchanged for $33.50 in cash. Prices on this page are historical; the last trade was July 20, 2022 at $32.96.
Natus Medical Incorporated stock price history
NTUS final trading statistics
- Final close
- $32.96
- Final trading day
- Jul 20, 2022
- Market cap at delisting
- $1.14B
- Shares outstanding
- 34.58M
- Final 52-week range
- $20.90 – $33.93
- Avg. volume (final 3 mo.)
- 437,380
- All-time high (split-adj.)
- $50.48 · Dec 2015
- All-time low (split-adj.)
- $3.15 · Oct 2002
- Return since IPO
- +128.1%
- Beta
- 0.23
- Book value / share
- $12.59
- Price / book
- 2.62
Natus Medical Incorporated annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $473.44M | $13.2M | $1.20 |
| FY2020 | $415.68M | -$16.6M | $0.39 |
| FY2019 | $495.18M | -$15.7M | $1.25 |
| FY2018 | $530.89M | -$22.9M | $1.42 |
| FY2017 | $500.97M | -$20.3M | $1.46 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Natus Medical Incorporated
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.
Natus Medical Incorporated stock FAQ
What happened to Natus Medical Incorporated stock?
Natus Medical Incorporated was taken private by ArchiMed on July 21, 2022. Shareholders received $33.50 in cash for each share. NTUS stock stopped trading on the Nasdaq, with a final close of $32.96 on July 20, 2022.
What did Natus Medical Incorporated shareholders receive?
Each NTUS share was converted into $33.50 in cash. The deal was valued at about $1.2 billion total equity value.
Is NTUS stock still trading?
No. NTUS was delisted from the Nasdaq on July 21, 2022 and no longer trades on a U.S. exchange.
What was the last price of NTUS stock?
NTUS closed at $32.96 on its final trading day, July 20, 2022, for a market value of about $1.14B.
What were Natus Medical Incorporated's revenue and earnings in its last full fiscal year?
Natus Medical Incorporated reported revenue of $473.44M and net income of $13.2M in fiscal 2021, its last full year as a public company.
When did Natus Medical Incorporated go public?
Natus Medical Incorporated stock began trading on July 31, 2001.